MedTrace Logo

Telephone Services for Participation in Colorectal Cancer Screening

NCT04348058 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6300

Last updated 2020-04-15

No results posted yet for this study

Summary

A multicentre randomized health services study within the population-based primary colonoscopy screening program (PCSP) in Poland. Individuals, aged 55-60 years, willl be randomized in a 1:1:1 ratio to arms: (1) Invitation by post, (2) Call Center or (2) Combined invitation methods. The primary outcome measure is rate of participation in screening colonoscopy. The sample size of 6 300 participants will detect 3 to 5 percentage point differences (depending on the arms comparison) in participation rate between groups with 80% power and significance level 0.05, using Ochran-Mantel-Haenszel test.

Conditions

  • Participation Rate, Patient

Interventions

BEHAVIORAL

Telephone recruitment to screening colonoscopy

Utilisation of dedicated call center for recruitment to screening program instead of traditional, paper invitation

BEHAVIORAL

Combined methods recruitment to screening colonoscopy

Utilisation of dedicated call center for recruitment to screening program in participants, who did not respond to traditional, paper invitation

Sponsors & Collaborators

  • Ministry of Health, Poland

    collaborator OTHER_GOV

  • Screening up, Poland

    collaborator UNKNOWN

  • Maria Sklodowska-Curie National Research Institute of Oncology

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
55 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-20
Primary Completion
2021-07-30
Completion
2021-08-30

Countries

  • Poland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04348058 on ClinicalTrials.gov